Research Paper Volume 13, Issue 2 pp 2851—2863
A novel methylation signature predicts inferior outcome of patients with PDAC
Figure 9. Differences in the types of drugs used between high-risk patients and low-risk patients. (A) The. high-risk patients, (B) The low-risk patients.